Patna: The Bihar Drug Control Department has conducted a statewide special inspection drive at more than 30 establishments and government healthcare institutions to ensure the quality of medicines, safe storage practices and proper distribution of drugs across the state.
The surprise inspections were carried out on Wednesday across several districts, covering medicine stores at government health facilities, pharmaceutical establishments and a drug manufacturing unit. The inspection teams examined the storage, handling, distribution and supply of government medicines, along with compliance with pharmaceutical regulations.
The department also conducted inspections in Patna‘s medicine market and at a pharmaceutical manufacturing facility as part of the special enforcement drive.
Surprise Inspections Conducted Across Multiple Districts
The special inspection campaign covered government healthcare institutions in Darbhanga, Aurangabad, Gaya, Madhubani, East Champaran, West Champaran, Muzaffarpur, Samastipur, Purnia, Munger, Madhepura, Kaimur, Bhagalpur, Katihar and Vaishali, among other districts.
The inspection teams examined the medicine stock available at government health facilities, focusing on proper storage, maintenance, supply and distribution of medicines.
The drive was aimed at ensuring that medicines supplied to government healthcare institutions meet quality standards and are stored under appropriate conditions.

Three Medicine Shops Inspected in Patna’s GM Road Market
As part of the special campaign, the Drug Control Department inspected three medicine establishments in the Govind Mitra Road (GM Road) pharmaceutical market in Patna.
The establishments inspected included:
- Mass Biocare, Anandi Palace
- New Ashok Pharma
- Popular Pharma
During the inspections, some medicines were found to be suspicious on preliminary examination. The concerned establishments also failed to produce purchase invoices for the medicines under scrutiny.
The inspection team collected samples of both allopathic and Ayurvedic medicines for laboratory examination to determine their quality and authenticity.
Samples Collected to Examine Medicine Quality and Authenticity
The collected samples will undergo testing to establish whether the medicines comply with prescribed quality standards.
The department will also investigate whether Ayurvedic medicines contain any unauthorised allopathic medicinal ingredients.
Further action will be taken in accordance with applicable rules and regulations based on the laboratory examination reports.
The department is examining the suspected irregularities to ensure compliance with pharmaceutical regulations and prevent the circulation of potentially substandard or unauthorised medicines.
Central Team Inspects Pharmaceutical Manufacturing Unit in Patna
A central inspection team also conducted an inspection at the pharmaceutical manufacturing facility of Asclepius Remedies Pvt. Ltd., located in Rukanpura, Patna.
The inspection was part of the broader enforcement exercise aimed at examining pharmaceutical manufacturing practices and ensuring compliance with applicable standards.
Bihar Drug Control Department Focuses on Medicine Safety and Regulatory Compliance
The statewide inspection drive is aimed at strengthening medicine safety and ensuring proper storage, handling, supply and distribution of drugs at government healthcare institutions.
The department is also focusing on compliance with pharmaceutical regulations in the medicine market and manufacturing sector.
Officials said necessary legal and administrative action is being taken in connection with irregularities detected during the inspections, in accordance with the applicable rules.
The campaign underscores the department’s efforts to maintain medicine quality, protect public health and strengthen regulatory oversight of pharmaceutical establishments across Bihar.














